Prothena Corp Public (PRTA) Receivables (2013 - 2023)
Prothena Corp Public (PRTA) posted quarterly Receivables of $5.2 million for Q4 2023, little changed quarter-over-quarter from $5.2 million in Q3 2023.
Prothena Corp Public (PRTA) Receivables (2013 - 2023) Analysis & Trends
Prothena Corp Public's Receivables history runs 10 years deep, the most recent figure standing at $5.2 million for Q4 2023.
- In Q4 2023, Receivables changed N/A year-over-year to $5.2 million; the TTM figure through Dec 2023 stood at $5.2 million (changed N/A YoY), while the FY2023 annual figure was $5.2 million, changed N/A from the prior year.
- Receivables for Q4 2023 stood at $5.2 million, roughly flat from $5.2 million in the prior quarter.
- The five-year high for Receivables was $5.2 million in Q3 2023, with the low at $1000.0 in Q1 2021.
- The 4-year median for Receivables is $56000.0 (2020), against an average of $869923.1.
- The sharpest annual moves came in 2019 and 2021: Receivables surged 3300.0% in 2019, then tumbled 99.43% in 2021.
- Prothena Corp Public's Receivables stood at $68000.0 in 2019, then slumped by 77.94% to $15000.0 in 2020, then soared by 426.67% to $79000.0 in 2021, then jumped by 6430.38% to $5.2 million in 2023.
- Business Quant data shows PRTA's Receivables at $5.2 million in Q4 2023, $5.2 million in Q3 2023, and $524000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.93 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.06 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.84 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 912.74 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 215.33 Mn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 5.16 Mn |
| Sep 30, 2023 | 5.16 Mn |
| Jun 30, 2023 | 524,000.00 |
| Sep 30, 2021 | 79,000.00 |
| Jun 30, 2021 | 3,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 22,000.00 |
| Jun 30, 2020 | 56,000.00 |
| Mar 31, 2020 | 174,000.00 |
| Dec 31, 2019 | 68,000.00 |
| Sep 30, 2019 | 42,000.00 |
| Mar 31, 2019 | 7,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Jun 30, 2018 | 8,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 240,000.00 |
| Sep 30, 2017 | 220,000.00 |
| Jun 30, 2017 | 30.24 Mn |
| Mar 31, 2017 | 271,000.00 |